Open | - |
Close | - |
Volume / Avg. | 0 / 300.951K |
Day Range | - - - |
52 Wk Range | 7.750 - 24.130 |
Market Cap | $494.770M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | % |
Days to Cover | 10.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.
There are no as such competitors for UroGen Pharma.
The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by HC Wainwright & Co. on Monday, March 18, 2024. The analyst firm set a price target for 54.00 expecting URGN to rise to within 12 months (a possible 272.41% upside). 12 analyst firms have reported ratings in the last year.
The stock price for UroGen Pharma (NASDAQ: URGN) is $14.5 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for UroGen Pharma.
UroGen Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for UroGen Pharma.
UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.